Stockreport

Indaptus Therapeutics to Present at the 2024 BIO CEO & Investor Conference

Indaptus Therapeutics, Inc.  (INDP) 
PDF NEW YORK, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative cance [Read more]